Good evening :)
$
₹
DaVita HealthCare Partners Inc

DaVita HealthCare Partners Inc

DVA

NYSE
Asset Logo

DaVita HealthCare Partners Inc

DVA

NYSE
$195.741.59% (+3.08)
$
₹
$195.741.59% (+3.08)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Care Facilities

Large Cap

With a market cap of $11.5B the stock is ranked 878

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

13.79
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

21.62
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$13.21
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.45
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

6.49%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 8 analysts reports

Buy
3 analysts
Hold
4 analysts
Sell
1 analyst

Price Upside

+22.02%

Earnings Growth

+35.15%

Rev. Growth

+3.77%

See Detailed Forecast

Company Profile

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.05
24.05
1Y Return
17.07%
17.07%
Buy Reco %
92.59
92.59
The Cigna Group
CI
The Cigna Group
P/E Ratio
12.21
12.21
1Y Return
11.63%
11.63%
Buy Reco %
70.83
70.83
Labcorp Holdings Inc.
LH
Labcorp Holdings Inc.
P/E Ratio
29.00
29.00
1Y Return
46.14%
46.14%
Buy Reco %
70.58
70.58
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
24.98
24.98
1Y Return
38.77%
38.77%
Buy Reco %
52.94
52.94
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
78.31%
78.31%
Buy Reco %
96.15
96.15
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 22.02% growth, versus a trailing 3-year CAGR of 32.13%.

2026
Current$182.17Baseline
Analyst Target - 1 year
Target$222.29+22.02%

All values in $

202220232024202520262027$111.53$155.86$200.19Target+22.02%
2026
Current$182.17Baseline
Analyst Target - 1 year
Target$222.29+22.02%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 3.77% growth, versus a trailing 3-year CAGR of 5.53%.

2025
Current$13.64Baseline
Forecast for Dec 2026
High$14.50+6.31%
Average$14.15+3.77%
Low$13.92+2.03%

All values in $ Billion

20212022202320242025202611.6111.6012.1412.8113.64Low+2.03%Average+3.77%High+6.31%
2025
Current$13.64Baseline
Forecast for Dec 2026
High$14.50+6.31%
Average$14.15+3.77%
Low$13.92+2.03%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 35.15% growth, versus a trailing 3-year CAGR of 22.21%.

2025
Current$10.86Baseline
Forecast for Dec 2026
High$14.98+37.95%
Average$14.68+35.15%
Low$14.34+32.04%

All values in $

2021202220232024202520269.115.958.389.810.86Low+32.04%Average+35.15%High+37.95%
2025
Current$10.86Baseline
Forecast for Dec 2026
High$14.98+37.95%
Average$14.68+35.15%
Low$14.34+32.04%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

3.6
0.2
3.4
0.1
3.5
0.2
3.5
0.2
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue3.183.263.293.223.373.423.613.413.553.57
Net Income0.220.210.250.160.190.150.230.190.260.22
Net Profit Margin6.98%6.57%7.87%5.05%5.89%4.39%6.47%5.78%7.46%6.23%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Care Facilities

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
DaVita HealthCare Partners Inc 13.7921.620.45
CVS Health Corp24.051.420.20
The Cigna Group12.211.840.81
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare DVA with any stock or ETF
Compare DVA with any stock or ETF
Comparing from
DVA
CVS
CI
Loading...

Frequently asked questions

  1. DaVita HealthCare Partners Inc (DVA) share price today is $195.74 as of November 5, 2026 at 9:33 PM IST. The stock touched a day high of $196.32 and a day low of $193.67.

  2. DaVita HealthCare Partners Inc stock trades on NYSE under the ticker symbol DVA.

  3. DaVita HealthCare Partners Inc's market capitalization is $11.45B as of November 5, 2026 at 9:33 PM IST.

  4. DaVita HealthCare Partners Inc's price-to-earnings (P/E) ratio is 13.79 as of November 5, 2026.

  5. DaVita HealthCare Partners Inc's price-to-book (P/B) ratio is 21.62 as of November 5, 2026.

  6. Yes, You can buy DaVita HealthCare Partners Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy DaVita HealthCare Partners Inc shares in three steps: 1. Search DaVita HealthCare Partners Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since DaVita HealthCare Partners Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in DaVita HealthCare Partners Inc (DVA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.051 shares at the current price of $195.74.

Loading...